Sara Elfarrash

Al Mansurah, DK, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Outcome-specific risk factors challenge universal dementia prevention priorities: Findings from the Egyptian Dementia Network Registry.

Outcome-specific risk factors challenge universal dementia prevention priorities: Findings from the Egyptian Dementia Network Registry.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 15, 2026

Novel anticancer effect of substituted imidazole derivatives against urothelial carcinoma: integrating In vitro screening and molecular docking for target kinases.

Novel anticancer effect of substituted imidazole derivatives against urothelial carcinoma: integrating In vitro screening and molecular docking for target kinases.

Journal: BMC cancer

Published: July 09, 2025

Synergistic Neuroprotection in Tauopathic Mice via Green-Synthesized Silver Nanoparticles Co-delivering Methylene Blue and Moringa oleifera.

Synergistic Neuroprotection in Tauopathic Mice via Green-Synthesized Silver Nanoparticles Co-delivering Methylene Blue and Moringa oleifera.

Journal: Molecular neurobiology

Published: July 03, 2025

The Egyptian Dementia Network (EDN): Baseline characteristics from the first dementia registry in an African Arab country.

The Egyptian Dementia Network (EDN): Baseline characteristics from the first dementia registry in an African Arab country.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 01, 2025

APOE genetic variability in an Egyptian cohort of PD.

APOE genetic variability in an Egyptian cohort of PD.

Journal: Frontiers in neuroscience

Published: February 19, 2025

The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization.

The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization.

Journal: European journal of pharmacology

Published: August 25, 2024

A novel phosphodiesterase 5 inhibitor, RF26, improves memory impairment and ameliorates tau aggregation and neuroinflammation in the P301S tauopathy mouse model of Alzheimer's disease.

A novel phosphodiesterase 5 inhibitor, RF26, improves memory impairment and ameliorates tau aggregation and neuroinflammation in the P301S tauopathy mouse model of Alzheimer's disease.

Journal: Experimental neurology

Published: August 19, 2024

Validation of harmonized cognitive assessment protocol within the Egyptian context.

Validation of harmonized cognitive assessment protocol within the Egyptian context.

Journal: Social psychiatry and psychiatric epidemiology

Published: June 27, 2024

MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity.

MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity.

Journal: NPJ Parkinson's disease

Published: June 26, 2024

The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson's disease.

The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: May 21, 2024

Impairment of Nrf2 signaling in the hippocampus of P301S tauopathy mice model aligns with the cognitive impairment and the associated neuroinflammation.

Impairment of Nrf2 signaling in the hippocampus of P301S tauopathy mice model aligns with the cognitive impairment and the associated neuroinflammation.

Journal: Journal of inflammation (London, England)

Published: January 03, 2024

Anti-proliferative activity of RIHMS-Qi-23 against MCF-7 breast cancer cell line is through inhibition of cell proliferation and senescence but not inhibition of targeted kinases.

Anti-proliferative activity of RIHMS-Qi-23 against MCF-7 breast cancer cell line is through inhibition of cell proliferation and senescence but not inhibition of targeted kinases.

Journal: BMC cancer

Published: July 29, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026